Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Survival of the Insignia Stem in Total Hip Arthroplasty

NCT: NCT05313321 · ACTIVE_NOT_RECRUITING

NCT IDNCT05313321
StatusACTIVE_NOT_RECRUITING
Start Date2022-03-17
Completion2028-03
SponsorUniversity of Utah (OTHER)
First posted
Last updated

Brief Summary

The investigators primary objective of this study is to evaluate radiographic fit and fill of the Insignia stem and identify risk factors for aseptic failure. The investigators hypotheses being tested is: the newly designed Insignia stem demonstrates acceptable radiographic fit and fill by reviewing radiolucent lines \<2mm.

Frequently Asked Questions

What is Survival of the Insignia Stem in Total Hip Arthroplasty?

Survival of the Insignia Stem in Total Hip Arthroplasty is a clinical trial registered under NCT05313321. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05313321?

The current status of NCT05313321 (Survival of the Insignia Stem in Total Hip Arthroplasty) is: ACTIVE_NOT_RECRUITING.

When did Survival of the Insignia Stem in Total Hip Arthroplasty start?

Survival of the Insignia Stem in Total Hip Arthroplasty started on 2022-03-17.

Related Devices

K211703Insignia Hip StemStryker Orthopaedics K220731Insignia Hip Stem, Restoration Modular 115mm Conical Distal StemStryker

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑